Celltrion And Rani Partner For Oral Adalimumab
Deal For Humira Rival Builds On Collaboration For Oral Version Of Ustekinumab
Celltrion has doubled down on its alliance with Rani Therapeutics for oral pill versions of biosimilars by adding adalimumab to an existing collaboration covering ustekinumab.
